CN Patent

CN102525911B — 一种溴甲纳曲酮注射液及其制备方法

Assigned to NANJING CUCCESS PHARMACEUTICAL CO Ltd · Expires 2013-09-18 · 13y expired

What this patent protects

本发明涉及一种溴甲纳曲酮注射液，由溴甲纳曲酮、氯化钠、甘氨酸、磷酸、pH调节剂和注射用水制备而成，其中，溴甲纳曲酮的浓度为20mg/mL、氯化钠的浓度为5～12mg/mL、甘氨酸的浓度为0.1～0.5mg/mL、磷酸的浓度为0.6～2.5mg/mL，采用pH调节剂调注射液的pH为3.0～4.0。本发明还提供了溴甲纳曲酮注射液的制备方法。本发明可显著降低溴甲纳曲酮注射液所引发的腹泻发生率。

USPTO Abstract

本发明涉及一种溴甲纳曲酮注射液，由溴甲纳曲酮、氯化钠、甘氨酸、磷酸、pH调节剂和注射用水制备而成，其中，溴甲纳曲酮的浓度为20mg/mL、氯化钠的浓度为5～12mg/mL、甘氨酸的浓度为0.1～0.5mg/mL、磷酸的浓度为0.6～2.5mg/mL，采用pH调节剂调注射液的pH为3.0～4.0。本发明还提供了溴甲纳曲酮注射液的制备方法。本发明可显著降低溴甲纳曲酮注射液所引发的腹泻发生率。

Drugs covered by this patent

methylnaltrexone-bromide (METHYLNALTREXONE BROMIDE)

Patent Metadata

Patent number: CN102525911B
Jurisdiction: CN
Classification: —
Expires: 2013-09-18
Drug substance claim: No
Drug product claim: No
Assignee: NANJING CUCCESS PHARMACEUTICAL CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.